Oncogenic viruses rewire the epigenome in human cancer
Viruses contribute to approximately 15–20% of global cancer cases, yet the full spectrum of their oncogenic mechanisms continues to be uncovered. Beyond the classical roles of genome integration, chronic inflammation, and immune evasion, mounting evidence reveals that oncogenic viruses—including the...
Saved in:
| Main Authors: | Jhommara Bautista, Andrés Lopez-Cortes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1617198/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context
by: Poyee Lau, et al.
Published: (2025-08-01) -
Peripheral clocks and systemic zeitgeber interactions: from molecular mechanisms to circadian precision medicine
by: Jhommara Bautista, et al.
Published: (2025-05-01) -
Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01) -
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01) -
Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01)